Nitric oxide is elicited and inhibits viral replication in pigs infected with porcine respiratory coronavirus but not porcine reproductive and respiratory syndrome virus.
There is little information on the role of nitric oxide (NO) in innate immunity to respiratory coronavirus (CoV) infections. We examined NO levels by Greiss assay in bronchoalveolar lavage (BAL) of pigs infected with either porcine respiratory coronavirus (PRCV) or porcine reproductive and respiratory syndrome virus (PRRSV), a member of Nidovirales, like CoV. The antiviral effects of NO on these two viruses were tested in an in vitro system using a NO donor, S-nitroso-N-acetylpenicillamine (SNAP). We detected a large increase in NO levels in BAL fluids of PRCV-infected pigs, but not in PRRSV-infected pigs. Pulmonary epithelial cell necrosis induced by PRCV coincided with increased NO. Moreover, NO levels in cell culture medium of PRRSV-infected alveolar macrophages (AMs) did not differ from that of mock-infected AMs. Antiviral assays showed that NO significantly inhibited PRCV replication in swine testicular (ST) cells, whereas PRRSV was not susceptible to NO based on the conditions tested. Our study suggests that unlike PRRSV which induces apoptosis in AMs, respiratory CoVs such as PRCV that infect pulmonary epithelial cells and cause cytolysis, induce NO production in the respiratory tract. Thus, NO may play a role in innate immunity to respiratory CoV infections by inhibiting viral replication.
Jung
Kwonil
K
Food Animal Health Research Program, Ohio Agricultural Research and Development Center, Department of Veterinary Preventive Medicine, The Ohio State University, 1680 Madison Ave., Wooster, OH 44691, USA.
Gurnani
Ashita
A
Renukaradhya
Gourapura J
GJ
Saif
Linda J
LJ
D000818:Animals; D001992:Bronchoalveolar Lavage Fluid / Q000737:chemistry / Q000821:virology; D018352:Coronavirus Infections / Q000276:immunology / Q000662:veterinary* / Q000821:virology; D008297:Male; D009569:Nitric Oxide / Q000276:immunology*; D020030:Nitric Oxide Donors / Q000494:pharmacology; D019318:Porcine Reproductive and Respiratory Syndrome / Q000276:immunology* / Q000821:virology; D045722:Porcine Respiratory Coronavirus / Q000276:immunology*; D019316:Porcine respiratory and reproductive syndrome virus / Q000276:immunology*; D011897:Random Allocation; D012140:Respiratory Tract Diseases / Q000276:immunology / Q000662:veterinary* / Q000821:virology; D026423:S-Nitroso-N-Acetylpenicillamine / Q000494:pharmacology; D013047:Specific Pathogen-Free Organisms; D018709:Statistics, Nonparametric; D013552:Swine; D014779:Virus Replication / Q000276:immunology
D020030:Nitric Oxide Donors; D009569:Nitric Oxide; D026423:S-Nitroso-N-Acetylpenicillamine
J Virol. 2005 Feb;79(3):1966-9
15650225
Immunology. 2000 Nov;101(3):300-8
11106932
Res Vet Sci. 1990 Mar;48(2):165-9
2159175
Vet Immunol Immunopathol. 1998 Feb 27;61(2-4):279-89
9613441
J Gen Virol. 2009 Nov;90(Pt 11):2713-2723
19656969
J Virol. 1997 Mar;71(3):2202-10
9032354
J Virol. 2007 Dec;81(24):13681-93
17942563
Arch Virol. 2008;153(8):1453-65
18563285
J Virol. 2008 May;82(9):4420-8
18287230
Free Radic Biol Med. 2006 Jul 1;41(1):19-28
16781449
J Vet Med B Infect Dis Vet Public Health. 2004 Mar;51(2):72-6
15030604
Immunobiology. 2006;211(6-8):511-24
16920490
Vet J. 2008 Sep;177(3):345-51
17644436
News Physiol Sci. 2001 Aug;16:185-90
11479370
Am J Pathol. 2007 Apr;170(4):1136-47
17392154
Rev Sci Tech. 2004 Aug;23(2):643-60
15702725